Results 11 to 20 of about 818,749 (164)

Management of carbapenem-resistant Enterobacteriaceae infections [PDF]

Clinical Microbiology and Infection, 2019
Carbapenem resistance is defined as in vitro non-susceptibility to any carbapenem and/or documented production of a carbapenemase. This feature has rapidly spread worldwide among clinical isolates of Enterobacteriaceae, mostly Klebsiella spp., and is associated with diverse molecular mechanisms. Carbapenem resistance is often associated with resistance
Durante-Mangoni, Emanuele, Andini, Roberto, Zampino, Rosa   +2 more
openaire   +4 more sources

Detection of Carbapenem-resistant Enterobacteriaceae by Real-Time PCR and Assessment of Hospitalization Related Risk Factors Associated with their Fecal Carriage: A Case-control Study [PDF]

Journal of Pure and Applied Microbiology, 2022
Opportunistic behavior of commensal bacteria during severe infection, especially of the intestine is always considered as a predisposing threat for the severely ill patient admitted to hospitals.
Ravikant, Preeti Kumari, Manoj Kumar, Partha Roy, M. Jeya   +4 more
doaj   +2 more sources

Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections [PDF]

Open Forum Infectious Diseases, 2015
Abstract This article provides a comprehensive review of currently available treatment options for infections due to carbapenem-resistant Enterobacteriaceae (CRE). Antimicrobial resistance in Gram-negative bacteria is an emerging and serious global public health threat.
Morrill, Haley J., Pogue, M., Kaye, Keith S., LaPlante, Kerry L.   +3 more
openaire   +5 more sources

Resistance Pattern of Carbapenem on Enterobacteriaceae

Journal of Nepal Medical Association, 2018
Introduction: Gram negative bacilli are the important causes of common clinical infections. Carbapenem resistant Enterobacteriaceae are considered as important public health threat and is classified as urgent by the Centers of Disease Control and ...
Khilasa Pokharel, Bishwa Raj Dawadi, Chandra Prakash Bhatta, Satish Gupte, Beena Jha   +4 more
doaj   +2 more sources

Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes [PDF]

Diagnostic Microbiology and Infectious Disease, 2013
The emergence of carbapenem resistance in Enterobacteriaceae is an important threat to global health. Reported outcomes of infections with carbapenem-resistant Enterobacteriaceae (CRE) are poor. Very few options remain for the treatment of these virulent organisms.
David, van Duin, Keith S, Kaye, Elizabeth A, Neuner, Robert A, Bonomo   +3 more
openaire   +4 more sources

Antibiotic Susceptibility Patterns for Carbapenem-Resistant Enterobacteriaceae

International Journal of Microbiology, 2023
Carbapenem is a broad-spectrum beta-lactam antibiotic considered the last choice for the treatment of antibiotic-resistant Gram-negative bacteria. Thus, the increasing rate of carbapenem resistance (CR) in Enterobacteriaceae is an urgent public health threat.
Shahnaz Armin, Fatemeh Fallah, Abdollah Karimi, Fereshteh Karbasiyan, Masoud Alebouyeh, Sedigheh Rafiei Tabatabaei, Maryam Rajabnejad, Roxana Mansour Ghanaie, Seyed Alireza Fahimzad, Nafiseh Abdollahi, Hannan Khodaei, Leila Azimi   +11 more
openaire   +4 more sources

Carbapenem-Resistant Enterobacteriaceae [PDF]

Clinics in Laboratory Medicine, 2017
Carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a major threat. Commonly used antibiotics are generally inactive against CRE. Therefore, timely detection of CRE is of paramount importance. Among CRE, those producing carbapenem-hydrolyzing β-lactamase enzymes (carbapenemase-producing Enterobacteriaceae) are particularly of concern because ...
Alina, Iovleva, Yohei, Doi
  +9 more sources

Deaths Attributable to Carbapenem-ResistantEnterobacteriaceaeInfections

Emerging Infectious Diseases, 2014
We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012. Attributable death was defined as the difference in all-cause deaths between patients with carbapenem-resistant infections and those with carbapenem-susceptible infections.
Matthew E. Falagas, Giannoula S. Tansarli, Drosos E. Karageorgopoulos, Konstantinos Z. Vardakas   +3 more
openaire   +4 more sources

Carbapenem Resistance In Enterobacteriaceae [PDF]

Sohag Medical Journal, 2020
Carbapenem resistance is now a public health concern worldwide. Carbapenem is considered the last resort antimicrobial drug used for treatment of hospital care associated infection and community acquired infection that resistant to all other β-lactam drugs. There are a different mechanisms by which bacteria become resistant to carbapenem drug including
Radwa Farag, hadir Elmahllawy, Laila Yousef, Hasnaa Abo-Elwafa   +3 more
openaire   +1 more source

Carbapenem-Resistant Enterobacteriaceae Infections in Children [PDF]

Current Infectious Disease Reports, 2015
Carbapenem-resistant Enterobacteriaceae (CRE) are an emerging global public health threat. Infections due to CRE are associated with significant morbidity and mortality. Few therapeutic options are available for treatment of these infections, and optimal antibiotic treatment regimens are unclear.
Kathleen, Chiotos, Jennifer H, Han, Pranita D, Tamma   +2 more
openaire   +2 more sources